Accelerometer-derived physical activity and mortality in individuals with type 2 diabetes

Nat Commun. 2024 Jun 17;15(1):5164. doi: 10.1038/s41467-024-49542-0.

Abstract

Physical activity (PA) has been shown to reduce diabetes mortality, but largely based on imprecise self-reported data, which may hinder the development of related recommendations. Here, we perform a prospective cohort study of 19,624 individuals with type 2 diabetes (T2D) from the UK Biobank with a median follow-up of 6.9 years. Duration and intensity of PA are measured by wrist-worn accelerometers over a 7-day period. We observe L-shaped associations of longer duration of PA, regardless of PA intensity, with risks of all-cause and cancer mortality, as well as a negatively linear association with cardiovascular disease mortality. 12.7%, 15.8%, and 22.3% of deaths are attributable to the lowest level of light-intensity, moderate-intensity PA, and vigorous-intensity PA, respectively. Collectively, our findings provide insights for clinical guidelines that should highlight the potential value of adherence to greater intensity and duration of PA for patients with T2D.

MeSH terms

  • Accelerometry* / instrumentation
  • Adult
  • Aged
  • Cardiovascular Diseases / mortality
  • Diabetes Mellitus, Type 2* / mortality
  • Exercise*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / mortality
  • Prospective Studies
  • United Kingdom / epidemiology